Expanding Options with Transcatheter Aortic Valve Replacement

The Harrington Heart & Vascular Institute at University Hospitals Cleveland Medical Center is a high volume program for transcatheter aortic valve replacement (TAVR), and the nation’s first training site for the minimalist, percutaneous conscious-sedation approach to TAVR. It is the only site in Northeast Ohio to offer TAVR for low risk severe aortic stenosis patients through the Medtronic Evolut R Low Risk trial, in addition to FDA approved indications for intermediate and high risk populations.

Guilherme Attizzani, MD, Co-Director, Valve & Structural Heart Disease Center, University Hospitals Harrington Heart & Vascular Institute, John C. Haugh Valve Fellow, University Hospitals Cleveland Medical Center, Assistant Professor of Medicine, Case Western Reserve University School of Medicine

Alan Markowitz, MD, Chief Surgical Officer, University Hospitals Harrington Heart & Vascular Institute, Co-Director, Valve & Structural Heart Disease Center, University Hospitals Harrington Heart & Vascular Institute, Marcella “Dolly” Haugh Chair in Valvular Surgery, University Hospitals Cleveland Medical Center, Clinical Assistant Professor of Surgery, Case Western Reserve University School of Medicine

Angela Davis, RN, Assistant Nurse Manager, Valve & Structural Heart Disease Center University Hospitals Harrington Heart & Vascular Institute

This video was recorded and produced by University Hospitals, Cleveland, Ohio, November 2016.